路特可以预测死亡率吗? 使用随机森林算法的分析
Jonne Åkerla1,2, Jaakko Nevalainen3, Jori S Pesonen4
1Department of Urology, Tampere University Hospital, Tampere, Finland.
Clinical interventions in aging
|February 19, 2024
概括
下尿道症状 (LUTS) 可以预测男性的死亡率. 然而,当患者的背景信息已知时,LUTS并不能显著改善死亡率预测.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 老年学是一门学科.
- 数据科学数据科学数据科学
背景情况:
- 下尿道症状 (LUTS) 在老年男性中很常见.
- 预测全因死亡率对于公共卫生和临床决策至关重要.
- 机器学习算法为死亡率预测提供了新的方法.
研究的目的:
- 用 LUTS 评估一个随机森林 (RF) 算法来预测全因死亡率.
- 与人口统计和医疗因素相比,评估LUTS在死亡率预测中的附加值.
- 探索RF在分析死亡风险的复杂健康数据中的实用性.
主要方法:
- 一个以人口为基础的2663名男性 (出生于1924,1934,1944) 的队列被跟踪到2018年.
- 使用丹麦前列腺症状评分 (DAN-PSS-1) 评估了下尿道症状 (LUTS).
- 随机森林 (RF) 算法被开发用于使用LUTS,人口,医学和行为因素来预测五年死亡率.
主要成果:
- 基于LUTS的射频算法实现了0.60的AUC,用于预测五年死亡率.
- 包括LUTS和其他因素在内的扩展射频算法产生了0.73.7的AUC.
- 一个不包括LUTS的算法获得了0.71的AUC,表明LUTS提供了最小的额外预测值.
结论:
- 使用LUTS的随机森林 (RF) 算法可以预测群体层面的全因死亡率.
- 在临床实践中,当患者的背景被充分记录时,LUTS不太可能提高死亡率预测的准确性.
- 进一步的研究可能会探索将LUTS整合到特定人群的更广泛的预测模型中.
相关概念视频
Survival Tree
85
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
85
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Introduction To Survival Analysis
236
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
236
Assumptions of Survival Analysis
127
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
127
Actuarial Approach
78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78


